Episode 384: Talking about personalized medicine with Tim Caulfield
In episode 384, James and Mike invite Tim Caulfield (author, professor and lawyer) to talk about the marketing of personalized medicine. We find out that most of the marketing is absurd. We also figure out that personalized medicine is being done all the time but it rarely if ever requires knowledge of any genetic testing results.
3) Shattuck lecture–medical and societal consequences of the Human Genome Project
4) Representing a “revolution”: how the popular press has portrayed personalized medicine
5) Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial
6) Genetic determinants of common obesity and their value in prediction.
7) Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis
8) Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial
9) Gene Environment Risk Assessment and Colorectal Cancer Screening in an Average Risk Population: A Randomized, Controlled Trial
10) Lifestyle Advice Combined with Personalized Estimates of Genetic or Phenotypic Risk of Type 2 Diabetes, and Objectively Measured Physical Activity: A Randomized Controlled Trial
11) Born Fat: The Relations Between Weight Changeability Beliefs and Health Behaviors and Physical Health
12) The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis
13) Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study
14) Why Are Some Population Interventions for Diet and Obesity More Equitable and Effective Than Others? The Role of Individual Agency